About ProSomnus
ProSomnus is a company based in Dublin (United States) founded in 2016. ProSomnus has raised $12.68 million across 6 funding rounds from investors including Spring Mountain Capital, Cetuscapitalpartners and HealthpointCapital. ProSomnus offers products and services including ProSomnus Device and Home Sleep Test. ProSomnus operates in a competitive market with competitors including ResMed, AeroCare Holdings, BMC Medical, Sommetrics and ApniCure, among others.
- Headquarter Dublin, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Prosomnus Sleep Technologies
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.68 M (USD)
in 6 rounds
-
Latest Funding Round
$38 M (USD), Post-IPO
Feb 19, 2026
-
Investors
Spring Mountain Capital
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ProSomnus
ProSomnus offers a comprehensive portfolio of products and services, including ProSomnus Device and Home Sleep Test.
Oral appliance that holds jaw forward to treat sleep apnea and snoring.
Convenient test to detect sleep apnea for patients at home.
People of ProSomnus
Unlock access to complete
Unlock access to complete
Funding Insights of ProSomnus
ProSomnus has successfully raised a total of $12.68M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $38 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ProSomnus
ProSomnus has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Spring Mountain Capital, Cetuscapitalpartners and HealthpointCapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on multiple sectors
|
Locked | Locked | Locked | |
|
HealthpointCapital is focused on private equity in musculoskeletal healthcare.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for ProSomnus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ProSomnus
Investment portfolio details for ProSomnus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ProSomnus
Detailed financials for ProSomnus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prosomnus Comparisons
Peer comparison for ProSomnus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ProSomnus
ProSomnus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ResMed, AeroCare Holdings, BMC Medical, Sommetrics and ApniCure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic devices to treat sleep apnea and respiratory disorders
|
|
| Locked | Locked | Locked |
Provider of medical devices for obstructive respiratory diseases and sleep apnea
|
|
| Locked | Locked | Locked |
Respiratory devices including ventilators, masks, and oxygen therapy are manufactured.
|
|
| Locked | Locked | Locked |
Sommetrics is focused on diagnosing, treating and monitoring Obstructive Sleep Effect.
|
|
| Locked | Locked | Locked |
Home-use devices for sleep apnea treatment are developed and commercialized.
|
Detailed competitors of ProSomnus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prosomnus
Complete news archive for ProSomnus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ProSomnus
ProSomnus was founded in 2016.
ProSomnus is headquartered in Dublin, United States.
ProSomnus is a funded company, having raised a total of $12.68M across 6 funding rounds to date.
Technologies for sleep and snoring management in dental care are developed by ProSomnus, founded in 2016 and based in Dublin, United States. The MicrO2 device is designed to advance the lower jaw forward, thereby alleviating snoring and obstructive sleep apnea symptoms by repositioning throat tissues. Tongue space is provided, allowing the mouth to open and close during use. Operations focus on dental settings for patient treatment.
ProSomnus's top competitors include ResMed, BMC Medical and React Health.
ProSomnus offers ProSomnus Device and Home Sleep Test.
ProSomnus has 4 investors. Key investors include Spring Mountain Capital, Cetuscapitalpartners, HealthpointCapital, and Catalio Capital Management.